37, 377394 e9
1) Drink water (ok, that's really healthy, but no fun at all) 2) If possible, get the drink directly from the can or bottle, or 3) Check its sugar
1) Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity PubMed Central (PMC)
Significant heterogeneity was observed between insulin and semaglutide recipients regarding ethnicity, age, sex, diagnosis of obesity, certain cardiovascular conditions, and AD-related risk factors
A: Many clients feel a mild boost within 2448 hours, with more noticeable improvements in energy and focus over 13 weeks
"Obesity Drugs: The Next Wave of GLP-1 Competition." September 2024